Day: November 9, 2026
GLP
Pharmaceutical
Regulation
Drug Research and Development Pipeline Breakdown
The drug development lifecycle is a multi-phase, high-risk process requiring significant capital investment. Out of thousands of compounds screened during initial discovery, fewer than 10% that enter clinical trials receive final regulatory approval. Stage Average Time...